Bruker Corporation to Present at Investor Conferences

Rhea-AI Summary

Bruker Corporation (Nasdaq: BRKR) announced its participation in two upcoming virtual conferences. The 10th Annual SVB Leerink Healthcare Conference will take place on February 25, 2021, at 8:40 a.m. ET, featuring Chairman Frank Laukien. Following this, the Cowen 41st Annual Health Care Conference is scheduled for March 2, 2021, at 11:10 a.m. ET, with CFO Gerald Herman. Live audio webcasts will be available on the Company's Investor Relations website, with replays for 30 days post-event.

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences:

10^th Annual SVB Leerink Healthcare Conference

Thursday, February 25, 2021, at 8:40 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer

Cowen 41^st Annual Health Care Conference

Tuesday, March 2, 2021, at 11:10 a.m. Eastern Time
Gerald Herman, Chief Financial Officer

Live audio webcasts of the virtual “fireside chat” sessions will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays will be posted on Bruker’s Investor Relations website after each event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005308/en/

FAQ

When is Bruker Corporation participating in the SVB Leerink Healthcare Conference?

Bruker Corporation will participate in the SVB Leerink Healthcare Conference on February 25, 2021, at 8:40 a.m. Eastern Time.

Who will represent Bruker at the Cowen 41st Annual Health Care Conference?

Gerald Herman, the Chief Financial Officer, will represent Bruker at the Cowen 41st Annual Health Care Conference on March 2, 2021, at 11:10 a.m. Eastern Time.

Where can I access the live webcasts for Bruker's conference events?

Live audio webcasts for Bruker's conference events can be accessed on the Company's Investor Relations website.

How long will the replays of Bruker's conference presentations be available?

Replays of Bruker's conference presentations will be available for 30 days following each event.

What is Bruker Corporation's stock symbol?

Bruker Corporation's stock symbol is BRKR.